The Medicines and Healthcare products Regulatory Agency (MHRA) is advising people taking GLP-1 medication such as Ozempic, ...
An early clinical trial suggests a minimally invasive procedure called duodenal mucosal resurfacing may reduce weight regain after people stop drugs such as semaglutide or tirzepatide. Patients who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results